{"id":708,"date":"2024-02-07T09:58:47","date_gmt":"2024-02-07T09:58:47","guid":{"rendered":"https:\/\/ncdconnect.org\/?p=708"},"modified":"2025-06-18T09:03:09","modified_gmt":"2025-06-18T09:03:09","slug":"general-questions","status":"publish","type":"post","link":"https:\/\/ncdconnect.org\/fr\/general-questions\/","title":{"rendered":"POUR COMMENCER"},"content":{"rendered":"<div class=\"wp-block-uagb-container uagb-block-414ee438 alignfull uagb-is-root-container\"><div class=\"uagb-container-inner-blocks-wrap\">\n<div class=\"wp-block-uagb-advanced-heading uagb-block-cd3fcaa7\"><h2 class=\"uagb-heading-text\">QUESTIONS G\u00c9N\u00c9RIQUES<\/h2><\/div>\n<\/div><\/div>\n\n\n\n<p><\/p>\n\n\n<div class=\"wp-block-uagb-faq uagb-faq__outer-wrap uagb-block-55d30cbb uagb-faq-icon-row uagb-faq-layout-accordion uagb-faq-expand-first-true uagb-faq-inactive-other-true uagb-faq__wrap uagb-buttons-layout-wrap uagb-faq-equal-height\" data-faqtoggle=\"true\" role=\"tablist\"><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-949287ef wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-ad4d0ff1\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">qu'est-ce que ncdconnect ?<\/span><\/div><div class=\"uagb-faq-content\"><p>NCDconnect est une plateforme d\u2019approvisionnement num\u00e9rique con\u00e7ue pour am\u00e9liorer l\u2019acc\u00e8s \u00e0 des m\u00e9dicaments et dispositifs m\u00e9dicaux contre les maladies non transmissibles (MNT). Elle vise \u00e0 rendre ces produits de qualit\u00e9 garantie plus abordables dans les pays \u00e0 revenu faible et interm\u00e9diaire (PRFI). D\u00e9velopp\u00e9e par IDA Foundation en collaboration avec Solvoz, NCDconnect permet de rationaliser l'approvisionnement en fonction des besoins des organisations de soins de sant\u00e9 qui luttent contre les maladies non transmissibles.<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-2af973bd wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-ad4d0ff1\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">comment soutenez-vous l'appropriation locale et le d\u00e9veloppment durable ?<\/span><\/div><div class=\"uagb-faq-content\"><p>Nous nous engageons en faveur d'un d\u00e9veloppement men\u00e9 au niveau local avec des partenaires locaux, des ONG et Minist\u00e8res de la Sant\u00e9. \u00c9tant donn\u00e9 que NCDconnect fait partie d' <a href=\"https:\/\/www.idafoundation.org\/\" target=\"_blank\" rel=\"noopener\">IDA Foundation<\/a>, nous partageons le m\u00eame objectif : s'approvisionner localement pour 20 % de notre portefeuille de produits d'ici 2030. <a href=\"https:\/\/www.idafoundation.org\/en\/sustainability\" target=\"_blank\" rel=\"noopener\">En savoir plus sur l'engagement d'IDA en mati\u00e8re de d\u00e9veloppement durable<\/a>. NCDconnect n'est pas seulement un outil - cela fait partie d'un effort \u00e0 long terme pour construire des syst\u00e8mes de sant\u00e9 r\u00e9silients.<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-12e646af wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-12e646af\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">Qu'est-ce qui diff\u00e9rencie NCDconnect des autres plateformes d'approvisionnement ou fournisseurs de produits m\u00e9dicaux ?\u00a0\u00a0<\/span><\/div><div class=\"uagb-faq-content\"><p>NCDconnect a \u00e9t\u00e9 sp\u00e9cialement <strong>con\u00e7u pour am\u00e9liorer l'acc\u00e8s aux produits de sant\u00e9 li\u00e9s aux maladies non transmissibles (MNT) dans les pays \u00e0 revenu faible ou interm\u00e9diaire.<\/strong> Contrairement aux fournisseurs m\u00e9dicaux g\u00e9n\u00e9raux ou aux plateformes commerciales, <strong>NCDconnect est un organisme \u00e0 but non lucratif et ax\u00e9 sur les MNT,<\/strong>con\u00e7u pour aider les organismes de sant\u00e9 en leur proposant des prix \u00e9quitables, des outils pratiques et un approvisionnement fiable.<br>Notre catalogue sp\u00e9cialis\u00e9 est adapt\u00e9 aux besoins des pays et propose des sch\u00e9mas th\u00e9rapeutiques complets. Chaque produit pr\u00e9sent sur la plateforme est soumis \u00e0 un processus d'assurance qualit\u00e9 - qu'il soit pr\u00e9qualifi\u00e9 par l'OMS, approuv\u00e9 par une Autorit\u00e9 de R\u00e9glementation Stricte ou examin\u00e9 par IDA Foundation par le biais d'\u00e9valuations de dossiers internes.<br>Nous r\u00e9duisons \u00e9galement la complexit\u00e9 de l'approvisionnement en regroupant les produits et les fournisseurs en un seul endroit, minimisant ainsi les interm\u00e9diaires et les risques li\u00e9s \u00e0 la cha\u00eene d'approvisionnement. <strong>Soutenu par plus de 50 ans d'exp\u00e9rience d' <a href=\"https:\/\/www.idafoundation.org\/\" target=\"_blank\" rel=\"noopener\">IDA Foundation<\/a>,<\/strong>, NCDconnect favorise un approvisionnement plus efficace, transparent et adapt\u00e9 au contexte pour les soins li\u00e9s aux maladies non transmissibles.<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-f7cde450 wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-12e646af\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">La strat\u00e9gie d'approvisionnement de mon pays repose sur des appels d'offres. Comment NCDconnect s'aligne-t-elle sur cette approche ?<\/span><\/div><div class=\"uagb-faq-content\"><p>Nous comprenons que de nombreux gouvernements et organisations <strong>op\u00e8rent dans des cadres de passation de march\u00e9s bas\u00e9s sur des appels d'offres<\/strong>. Cependant, les appels d'offres peuvent souvent \u00eatre complexes, prendre du temps et \u00eatre difficiles \u00e0 g\u00e9rer - en particulier pour les besoins fragment\u00e9s en mati\u00e8re de MNT. Ils peuvent \u00e9galement entra\u00eener des <strong>lacunes involontaires en mati\u00e8re d'acc\u00e8s<\/strong> ou <strong>des interruptions de traitement<\/strong> pour des maladies chroniques telles que le diab\u00e8te et le cancer, pour lesquelles une disponibilit\u00e9 constante est essentielle. <br><br>L'objectif de NCDconnect est de travailler avec vous <strong>en tant que partenaire<\/strong>. Nous pouvons op\u00e9rer au sein des syst\u00e8mes d'appels d'offres si n\u00e9cessaire. Nous avons \u00e9galement \u00e9tabli des partenariats au niveau politique pour permettre l'approvisionnement parall\u00e8le,<strong>par le biais d'appels d'offres et de plateformes num\u00e9riques,<\/strong>donnant \u00e0 vos \u00e9quipes la flexibilit\u00e9 de s\u00e9lectionner les produits et les partenaires qui apportent le plus de valeur aux syst\u00e8mes de sant\u00e9 et aux patients. Que vous envisagiez un appel d'offres complet ou que vous recherchiez une solution plus rationnelle, <strong>notre \u00e9quipe est \u00e0 votre disposition pour vous conseiller en cons\u00e9quence.<\/strong><\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-347269b7 wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-12e646af\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">Quels pays peuvent utiliser NCDconnect ?\u00a0\u00a0<\/span><\/div><div class=\"uagb-faq-content\"><p>Toutes les organisations desservant les pays \u00e0 revenu faible ou interm\u00e9diaire tels que d\u00e9finis par la <a href=\"https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups\" data-type=\"link\" data-id=\"https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups\" target=\"_blank\" rel=\"noopener\">Banque Mondiale<\/a>.\u00a0\u00a0<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-5b8ae817 wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-12e646af\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">Qui peut utiliser NCDCONNECT ? \u00a0\u00a0<\/span><\/div><div class=\"uagb-faq-content\"><p>NCDconnect est con\u00e7u pour les organisations ax\u00e9es sur la sant\u00e9, telles que les minist\u00e8res de la sant\u00e9, les ONG, les organisations confessionnelles, les partenaires de mise en \u0153uvre et d'autres acheteurs institutionnels qui ach\u00e8tent des m\u00e9dicaments et des dispositifs m\u00e9dicaux li\u00e9s aux maladies non transmissibles.\u00a0<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-b550f511 wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-12e646af\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">L'UTILISATION DE NCDCONNECT EST-ELLE PAYANTE ? \u00a0\u00a0<\/span><\/div><div class=\"uagb-faq-content\"><p>Non, l'inscription et l'acc\u00e8s \u00e0 NCDconnect sont totalement gratuits. Vous ne payez que les produits, les frais d'exp\u00e9dition et les frais d'achat standard, qui sont inclus de mani\u00e8re transparente dans votre devis. Ces frais nous aident \u00e0 couvrir nos co\u00fbts op\u00e9rationnels, mais en tant qu'organisation \u00e0 but non lucratif, nous n'ajoutons pas de marges inutiles. Notre objectif est de maintenir des prix \u00e9quitables, transparents et ax\u00e9s sur l'impact.<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-93a0f9a2 wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-12e646af\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">Vos prix sont-ils comp\u00e9titifs ?  \u00a0\u00a0<\/span><\/div><div class=\"uagb-faq-content\"><p>Oui. En tant qu'entreprise sociale \u00e0 but non lucratif, nous ne nous concentrons pas sur les marges, mais sur le fait de rendre abordables et accessibles des produits dont la qualit\u00e9 est garantie. Nous proposons des prix \u00e9quitables gr\u00e2ce aux approvisionnements directs, aux achats group\u00e9s et \u00e0 nos d\u00e9cennies d'exp\u00e9rience dans la gestion de cha\u00eenes d'approvisionnement mondiales complexes.<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-ad4d0ff1 wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-ad4d0ff1\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">Comment la qualit\u00e9 des produits est-elle assur\u00e9e ?\u00a0\u00a0<\/span><\/div><div class=\"uagb-faq-content\"><p>Tous les produits r\u00e9pertori\u00e9s sont certifi\u00e9s OMS-PQ, SRA et\/ou par l\u2019Assurance Qualit\u00e9 d\u2019IDA Foundation. Pour plus d'informations sur les m\u00e9canismes d'Assurance Qualit\u00e9 d'IDA, consultez notre article sur nos engagements qualit\u00e9 (disponible en anglais seulement): <a href=\"https:\/\/ncdconnect.org\/fr\/combating-the-scourge-of-substandard-medicines-in-low-and-middle-income-countries-ida-foundations-commitment-to-quality-assurance\/\" data-type=\"link\" data-id=\"https:\/\/ncdconnect.org\/en\/combating-the-scourge-of-substandard-medicines-in-low-and-middle-income-countries-ida-foundations-commitment-to-quality-assurance\/\">IDA Foundation\u2019s Commitment to Quality Assurance<\/a>.\u00a0<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-82ff77d9 wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-ad4d0ff1\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">Les m\u00e9dicaments innovants sont-ils disponibles sur NCDconnect ?\u00a0\u00a0<\/span><\/div><div class=\"uagb-faq-content\"><p>Oui, le catalogue comprend \u00e0 la fois des m\u00e9dicaments g\u00e9n\u00e9riques et des m\u00e9dicaments innovants qui sont pr\u00e9qualifi\u00e9s pour une qualit\u00e9 garantie.<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-0bf2cb48 wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-0bf2cb48\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">Que puis-je trouver sur la plateforme num\u00e9rique d'approvisionnement NCDconnect, et pour quelles maladies ?<\/span><\/div><div class=\"uagb-faq-content\"><p>La plateforme offre un catalogue complet de m\u00e9dicaments et de dispositifs m\u00e9dicaux pour les quatre principales maladies non transmissibles (MNT) : le cancer, le diab\u00e8te, les maladies cardiovasculaires et les maladies respiratoires chroniques.<br>Notre s\u00e9lection est :<br>&#8211; <strong>Strat\u00e9gique<\/strong>: L'accent est mis sur les produits conformes \u00e0 la liste des m\u00e9dicaments essentiels de l'OMS, aux strat\u00e9gies nationales et aux priorit\u00e9s en mati\u00e8re de traitement des maladies.<br> &#8211; <strong>Adapt\u00e9e en permanence<\/strong>: Mise \u00e0 jour r\u00e9guli\u00e8re pour r\u00e9pondre \u00e0 la demande et aux besoin des patients, avec la contribution des parties prenantes et des fabricants pour assurer un meilleur acc\u00e8s.<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-acd3c35c wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-acd3c35c\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">Ne puis-je pas simplement acheter directement aupr\u00e8s des fabricants ou d\u2019un grossiste local ?<\/span><\/div><div class=\"uagb-faq-content\"><p>C\u2019est possible, mais NCDconnect apporte une r\u00e9elle valeur ajout\u00e9e en regroupant, sur une seule plateforme, des produits pr\u00e9s\u00e9lectionn\u00e9s et de qualit\u00e9 garantie \u2014 r\u00e9duisant ainsi la fragmentation, la complexit\u00e9 des achats et les risques associ\u00e9s. Tous les produits disponibles sur la plateforme sont issus d\u2019un processus de validation rigoureux : ils sont soit pr\u00e9qualifi\u00e9s par l\u2019OMS, approuv\u00e9s par une autorit\u00e9 de r\u00e9glementation stricte (SRA), ou <a href=\"https:\/\/www.idafoundation.org\/en\/quality\" target=\"_blank\" rel=\"noopener\">valid\u00e9s par IDA Foundation via un examen interne approfondi du dossier qualit\u00e9<\/a>. Cela garantit des standards \u00e9lev\u00e9s, adapt\u00e9s aux r\u00e9alit\u00e9s des syst\u00e8mes de sant\u00e9 des pays \u00e0 revenu faible ou interm\u00e9diaire.\nNous proposons \u00e9galement un accompagnement de bout en bout, des prix stables et une transparence totale, pour permettre aux organisations de renforcer leur impact en toute confiance.<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-dbc96e40 wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-acd3c35c\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">Existe-t-il une biblioth\u00e8que de connaissances ?\u00a0<\/span><\/div><div class=\"uagb-faq-content\"><p>Pas encore, mais cela ne saurait tarder ! Nous sommes en train de d\u00e9velopper une biblioth\u00e8que de connaissances avec des informations telles que l'expertise et les recommandations sur l'\u00e9quipement de d\u00e9pistage, les r\u00e9gimes, les traitements, les r\u00e9glementations, les enregistrements, les processus d'approvisionnement, etc. Si vous avez des demandes sp\u00e9cifiques concernant les connaissances de la plateforme, veuillez nous envoyer un courriel \u00e0 l'adresse suivante : <a href=\"mailto:ncd@idafoundation.org\">ncd@idafoundation.org<\/a>.\u00a0<\/p><\/div><\/div><\/div>\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\"><\/div>\n\n\n\n<div style=\"height:36px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"has-text-align-center\">Vous \u00eates acheteur et recherchez plus d\u2019informations ?<\/p>\n\n\n\n<p><\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"has-text-align-center\">Vous \u00eates fournisseur et recherchez plus d\u2019informations ?<\/p>\n\n\n\n<p><\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-16018d1d wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-background wp-element-button\" href=\"https:\/\/ncdconnect.org\/fr\/buyers\/\" style=\"background-color:#4f9ab0\">En savoir plus<\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-16018d1d wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-background wp-element-button\" href=\"https:\/\/ncdconnect.org\/fr\/suppliers\/\" style=\"background-color:#4f9ab0\">En savoir plus<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>En savoir plus sur l\u2019\u00e9ligibilit\u00e9, l\u2019assurance qualit\u00e9, la port\u00e9e du portefeuille et les ressources. <\/p>","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"<!-- wp:uagb\/container {\"block_id\":\"414ee438\",\"backgroundType\":\"color\",\"backgroundColor\":\"#4f9ab0\",\"variationSelected\":true,\"isBlockRootParent\":true,\"textColor\":\"#ffffff\",\"linkColor\":\"#4f9ab0\"} -->\n<div class=\"wp-block-uagb-container uagb-block-414ee438 alignfull uagb-is-root-container\"><div class=\"uagb-container-inner-blocks-wrap\"><!-- wp:uagb\/advanced-heading {\"block_id\":\"cd3fcaa7\",\"classMigrate\":true,\"headingAlign\":\"center\"} -->\n<div class=\"wp-block-uagb-advanced-heading uagb-block-cd3fcaa7\"><h2 class=\"uagb-heading-text\">General Questions<\/h2><\/div>\n<!-- \/wp:uagb\/advanced-heading --><\/div><\/div>\n<!-- \/wp:uagb\/container -->\n\n<!-- wp:paragraph -->\n<p><\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:uagb\/faq {\"block_id\":\"55d30cbb\",\"borderStyle\":\"\",\"borderWidth\":\"\",\"borderRadius\":\"\",\"borderColor\":\"\",\"schema\":\"{u0022@contextu0022:u0022https:\/\/schema.orgu0022,u0022@typeu0022:u0022FAQPageu0022,u0022@idu0022:u0022https:\/\/ncdconnect.org\/general-questions\/u0022,u0022mainEntityu0022:[{u0022@typeu0022:u0022Questionu0022,u0022nameu0022:u0022Which countries are eligible to use NCDconnect?\u00a0\u00a0u0022,u0022acceptedAnsweru0022:{u0022@typeu0022:u0022Answeru0022,u0022textu0022:u0022All organisations serving Low- and Middle-Income Countries (LMICs), as defined by the u003ca href=\\u0022https:\/\/data.worldbank.org\/indicator\/NY.GDP.MKTP.CD?locations=XN\\u0022 target=\\u0022_blank\\u0022 rel=\\u0022noreferrer noopener\\u0022u003eWorld Banku003c\/au003e.\u00a0\u00a0u0022}},{u0022@typeu0022:u0022Questionu0022,u0022nameu0022:u0022How is the quality of products ensured?\u00a0\u00a0u0022,u0022acceptedAnsweru0022:{u0022@typeu0022:u0022Answeru0022,u0022textu0022:u0022All listed products have certified WHO-PQ, SRA, and\/or IDA Quality Assured. For more information on IDA\u2019s quality assurance mechanisms, please see u003ca href=\\u0022https:\/\/ncdconnect.org\/en\/combating-the-scourge-of-substandard-medicines-in-low-and-middle-income-countries-ida-foundations-commitment-to-quality-assurance\/\\u0022 target=\\u0022_blank\\u0022 rel=\\u0022noreferrer noopener\\u0022u003eIDA Foundation\u2019s Commitment to Quality Assuranceu003c\/au003e.\u00a0u0022}},{u0022@typeu0022:u0022Questionu0022,u0022nameu0022:u0022What other disease areas will be included on the platform in the future?\u00a0\u00a0u0022,u0022acceptedAnsweru0022:{u0022@typeu0022:u0022Answeru0022,u0022textu0022:u0022Oncology and diabetes thereapeutics are currently in the Catalogue. You can expect the diagnostics portfolio\u00a0and all other NCDs by Q3 2024.\u00a0\u00a0u003cbru003e\u00a0u003cbru003eFollow u003ca href=\\u0022https:\/\/www.linkedin.com\/company\/ncdconnect\/\\u0022 target=\\u0022_blank\\u0022 rel=\\u0022noreferrer noopener\\u0022u003eNCDconnect on LinkedInu003c\/au003e for the most up-to-date information.u0022}},{u0022@typeu0022:u0022Questionu0022,u0022nameu0022:u0022Is there a knowledge library?\u00a0u0022,u0022acceptedAnsweru0022:{u0022@typeu0022:u0022Answeru0022,u0022textu0022:u0022Not yet; but it\u2019s coming! We are developing a knowledge library with information such as expertise and recommendations on screening equipment, regimens, treatment, regulations, registrations, procurement processes, etc. If you have specific requests for platform knowledge, please email us at: u003ca href=\\u0022mailto:ncd@idafoundation.org\\u0022 target=\\u0022_blank\\u0022 rel=\\u0022noreferrer noopener\\u0022u003encd@idafoundation.orgu003c\/au003e.\u00a0\u00a0u0022}}]}\",\"overallBorderTopWidth\":1,\"overallBorderLeftWidth\":1,\"overallBorderRightWidth\":1,\"overallBorderBottomWidth\":1,\"overallBorderTopLeftRadius\":2,\"overallBorderTopRightRadius\":2,\"overallBorderBottomLeftRadius\":2,\"overallBorderBottomRightRadius\":2,\"overallBorderStyle\":\"solid\",\"overallBorderColor\":\"#D2D2D2\"} -->\n<div class=\"wp-block-uagb-faq uagb-faq__outer-wrap uagb-block-55d30cbb uagb-faq-icon-row uagb-faq-layout-accordion uagb-faq-expand-first-true uagb-faq-inactive-other-true uagb-faq__wrap uagb-buttons-layout-wrap uagb-faq-equal-height\" data-faqtoggle=\"true\" role=\"tablist\"><!-- wp:uagb\/faq-child {\"block_id\":\"12e646af\",\"question\":\"Which countries are eligible to use NCDconnect?\u00a0\u00a0\",\"answer\":\"All organisations serving Low- and Middle-Income Countries (LMICs), as defined by the u003ca href=u0022https:\/\/data.worldbank.org\/indicator\/NY.GDP.MKTP.CD?locations=XNu0022 target=u0022_blanku0022 rel=u0022noreferrer noopeneru0022u003eWorld Banku003c\/au003e.\u00a0\u00a0\"} -->\n<div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-12e646af\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\"><span class=\"uagb-icon uagb-faq-icon-wrap\"><svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg><\/span><span class=\"uagb-icon-active uagb-faq-icon-wrap\"><svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg><\/span><span class=\"uagb-question\">Which countries are eligible to use NCDconnect?\u00a0\u00a0<\/span><\/div><div class=\"uagb-faq-content\"><p>All organisations serving Low- and Middle-Income Countries (LMICs), as defined by the <a href=\"https:\/\/data.worldbank.org\/indicator\/NY.GDP.MKTP.CD?locations=XN\" target=\"_blank\" rel=\"noreferrer noopener\">World Bank<\/a>.\u00a0\u00a0<\/p><\/div><\/div>\n<!-- \/wp:uagb\/faq-child -->\n\n<!-- wp:uagb\/faq-child {\"block_id\":\"ad4d0ff1\",\"question\":\"How is the quality of products ensured?\u00a0\u00a0\",\"answer\":\"All listed products have certified WHO-PQ, SRA, and\/or IDA Quality Assured. For more information on IDA\u2019s quality assurance mechanisms, please see u003ca href=u0022https:\/\/ncdconnect.org\/en\/combating-the-scourge-of-substandard-medicines-in-low-and-middle-income-countries-ida-foundations-commitment-to-quality-assurance\/u0022 target=u0022_blanku0022 rel=u0022noreferrer noopeneru0022u003eIDA Foundation\u2019s Commitment to Quality Assuranceu003c\/au003e.\u00a0\"} -->\n<div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-ad4d0ff1\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\"><span class=\"uagb-icon uagb-faq-icon-wrap\"><svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg><\/span><span class=\"uagb-icon-active uagb-faq-icon-wrap\"><svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg><\/span><span class=\"uagb-question\">How is the quality of products ensured?\u00a0\u00a0<\/span><\/div><div class=\"uagb-faq-content\"><p>All listed products have certified WHO-PQ, SRA, and\/or IDA Quality Assured. For more information on IDA\u2019s quality assurance mechanisms, please see <a href=\"https:\/\/ncdconnect.org\/en\/combating-the-scourge-of-substandard-medicines-in-low-and-middle-income-countries-ida-foundations-commitment-to-quality-assurance\/\" target=\"_blank\" rel=\"noreferrer noopener\">IDA Foundation\u2019s Commitment to Quality Assurance<\/a>.\u00a0<\/p><\/div><\/div>\n<!-- \/wp:uagb\/faq-child -->\n\n<!-- wp:uagb\/faq-child {\"block_id\":\"0bf2cb48\",\"question\":\"What other disease areas will be included on the platform in the future?\u00a0\u00a0\",\"answer\":\"Oncology and diabetes thereapeutics are currently in the Catalogue. You can expect the diagnostics portfolio\u00a0and all other NCDs by Q3 2024.\u00a0\u00a0u003cbru003e\u00a0u003cbru003eFollow u003ca href=u0022https:\/\/www.linkedin.com\/company\/ncdconnect\/u0022 target=u0022_blanku0022 rel=u0022noreferrer noopeneru0022u003eNCDconnect on LinkedInu003c\/au003e for the most up-to-date information.\"} -->\n<div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-0bf2cb48\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\"><span class=\"uagb-icon uagb-faq-icon-wrap\"><svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg><\/span><span class=\"uagb-icon-active uagb-faq-icon-wrap\"><svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg><\/span><span class=\"uagb-question\">What other disease areas will be included on the platform in the future?\u00a0\u00a0<\/span><\/div><div class=\"uagb-faq-content\"><p>Oncology and diabetes thereapeutics are currently in the Catalogue. You can expect the diagnostics portfolio\u00a0and all other NCDs by Q3 2024.\u00a0\u00a0<br>\u00a0<br>Follow <a href=\"https:\/\/www.linkedin.com\/company\/ncdconnect\/\" target=\"_blank\" rel=\"noreferrer noopener\">NCDconnect on LinkedIn<\/a> for the most up-to-date information.<\/p><\/div><\/div>\n<!-- \/wp:uagb\/faq-child -->\n\n<!-- wp:uagb\/faq-child {\"block_id\":\"acd3c35c\",\"question\":\"Is there a knowledge library?\u00a0\",\"answer\":\"Not yet; but it\u2019s coming! We are developing a knowledge library with information such as expertise and recommendations on screening equipment, regimens, treatment, regulations, registrations, procurement processes, etc. If you have specific requests for platform knowledge, please email us at: u003ca href=u0022mailto:ncd@idafoundation.orgu0022 target=u0022_blanku0022 rel=u0022noreferrer noopeneru0022u003encd@idafoundation.orgu003c\/au003e.\u00a0\u00a0\"} -->\n<div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-acd3c35c\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\"><span class=\"uagb-icon uagb-faq-icon-wrap\"><svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg><\/span><span class=\"uagb-icon-active uagb-faq-icon-wrap\"><svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg><\/span><span class=\"uagb-question\">Is there a knowledge library?\u00a0<\/span><\/div><div class=\"uagb-faq-content\"><p>Not yet; but it\u2019s coming! We are developing a knowledge library with information such as expertise and recommendations on screening equipment, regimens, treatment, regulations, registrations, procurement processes, etc. If you have specific requests for platform knowledge, please email us at: <a href=\"mailto:ncd@idafoundation.org\" target=\"_blank\" rel=\"noreferrer noopener\">ncd@idafoundation.org<\/a>.\u00a0\u00a0<\/p><\/div><\/div>\n<!-- \/wp:uagb\/faq-child --><\/div>\n<!-- \/wp:uagb\/faq -->","_et_gb_content_width":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[31],"tags":[],"class_list":["post-708","post","type-post","status-publish","format-standard","hentry","category-faq"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false,"et-pb-post-main-image":false,"et-pb-post-main-image-fullwidth":false,"et-pb-portfolio-image":false,"et-pb-portfolio-module-image":false,"et-pb-portfolio-image-single":false,"et-pb-gallery-module-image-portrait":false,"et-pb-post-main-image-fullwidth-large":false,"et-pb-image--responsive--desktop":false,"et-pb-image--responsive--tablet":false,"et-pb-image--responsive--phone":false},"uagb_author_info":{"display_name":"Callie Weber","author_link":"https:\/\/ncdconnect.org\/fr\/author\/callie\/"},"uagb_comment_info":0,"uagb_excerpt":"More on eligibility, QA, portfolio scope, and resources.","_links":{"self":[{"href":"https:\/\/ncdconnect.org\/fr\/wp-json\/wp\/v2\/posts\/708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ncdconnect.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ncdconnect.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ncdconnect.org\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/ncdconnect.org\/fr\/wp-json\/wp\/v2\/comments?post=708"}],"version-history":[{"count":34,"href":"https:\/\/ncdconnect.org\/fr\/wp-json\/wp\/v2\/posts\/708\/revisions"}],"predecessor-version":[{"id":2206,"href":"https:\/\/ncdconnect.org\/fr\/wp-json\/wp\/v2\/posts\/708\/revisions\/2206"}],"wp:attachment":[{"href":"https:\/\/ncdconnect.org\/fr\/wp-json\/wp\/v2\/media?parent=708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ncdconnect.org\/fr\/wp-json\/wp\/v2\/categories?post=708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ncdconnect.org\/fr\/wp-json\/wp\/v2\/tags?post=708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}